BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33499885)

  • 1. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics.
    Guo S; Liang Y; Liu L; Yin M; Wang A; Sun K; Li Y; Shi Y
    J Nanobiotechnology; 2021 Jan; 19(1):32. PubMed ID: 33499885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
    Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
    Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of surface charge on oral absorption of polymeric nanoparticles.
    Du XJ; Wang JL; Iqbal S; Li HJ; Cao ZT; Wang YC; Du JZ; Wang J
    Biomater Sci; 2018 Feb; 6(3):642-650. PubMed ID: 29412203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin.
    Zhou S; Deng H; Zhang Y; Wu P; He B; Dai W; Zhang H; Zhang Q; Zhao R; Wang X
    Mol Pharm; 2020 Jan; 17(1):239-250. PubMed ID: 31800258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vivo evaluation of papain-functionalized nanoparticles.
    Müller C; Perera G; König V; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2014 May; 87(1):125-31. PubMed ID: 24373995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles.
    Pereira de Sousa I; Steiner C; Schmutzler M; Wilcox MD; Veldhuis GJ; Pearson JP; Huck CW; Salvenmoser W; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):273-9. PubMed ID: 25576256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
    Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption.
    Liang Y; Ding R; Wang H; Liu L; He J; Tao Y; Zhao Z; Zhang J; Wang A; Sun K; Li Y; Shi Y
    Drug Deliv; 2022 Dec; 29(1):305-315. PubMed ID: 35037529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.